How should risk and ambiguity affect our charitable giving?

Lara Buchak (Princeton University)

GPI Working Paper No. 8 - 2022, published in Utilitas

Suppose we want to do the most good we can with a particular sum of money, but we cannot be certain of the consequences of different ways of making use of it. This paper explores how our attitudes towards risk and ambiguity bear on what we should do. It shows that risk-avoidance and ambiguity-aversion can each provide good reason to divide our money between various charitable organizations rather than to give it all to the most promising one. It also shows on how different attitudes towards risk and ambiguity affect whether we should give to an organization which does a small amount of good for certain or to one which does a large amount of good with some small, unknown probability.

Other working papers

Evolutionary debunking and value alignment – Michael T. Dale (Hampden-Sydney College) and Bradford Saad (Global Priorities Institute, University of Oxford)

This paper examines the bearing of evolutionary debunking arguments—which use the evolutionary origins of values to challenge their epistemic credentials—on the alignment problem, i.e. the problem of ensuring that highly capable AI systems are properly aligned with values. Since evolutionary debunking arguments are among the best empirically-motivated arguments that recommend changes in values, it is unsurprising that they are relevant to the alignment problem. However, how evolutionary debunking arguments…

Existential risks from a Thomist Christian perspective – Stefan Riedener (University of Zurich)

Let’s say with Nick Bostrom that an ‘existential risk’ (or ‘x-risk’) is a risk that ‘threatens the premature extinction of Earth-originating intelligent life or the permanent and drastic destruction of its potential for desirable future development’ (2013, 15). There are a number of such risks: nuclear wars, developments in biotechnology or artificial intelligence, climate change, pandemics, supervolcanos, asteroids, and so on (see e.g. Bostrom and Ćirković 2008). …